We designed a randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy of Acupoint application (AP) in the treatment of chronic stable angina pectoris (CSAP).
CHICAGO (Reuters) – Cardiovascular device maker Thoratec Corp. said on Monday it has received European marketing approval for the Thoratec IVAD, an […]
